editing - International Pharmaceutical Industry

Volume 15 Issue 2

Advancements of Gene Editing Technologies(CRISPR/Cas9)

An Introduction to Gene Editing – CRISPR-Cas9 The dynamic promise of gene editing for humans is the ability to precisely manipulate the sequence of the cell genom...

3 July 2023 Volume 15 Issue 2 Advancements | cell

Continue Reading →

News

Horizon Discovery enters into agreement with Roche Diagnostics to support the development of immunohistochemistry assays for oncology

Horizon Discovery Group plc, a global leader in gene editing and gene modulation technologies, today announces that it has entered into an agreement with Roche Diagn...

19 December 2017 News assay | biomarker

Continue Reading →

News

Sphere Fluidics and Geneva Biotech receive Eurostars genome editing grant

Sphere Fluidics, a company providing single cell analysis systems underpinned by its patented picodroplet technology, and Geneva Biotech, an EMBL spin-out devel...

28 November 2017 News biotech | DNA

Continue Reading →

News

Locus Biosciences raises $19 million series A for CRISPR-Cas3 Antimicrobials

Locus Biosciences has closed $19 million in Series A funding led by venture capital firm ARTIS Ventures with additional financing from notable institutional investor...

17 November 2017 News antibiotic | antimicrobial

Continue Reading →

News

IDT Provides Optimized Conditions for HDR in CRISPR Editing

As an advocate for the genomics age, Integrated DNA Technologies (IDT), has published a new application note on optimization of CRISPR-Cas9 for homology-directed rep...

16 November 2017 News CRISPR-Cas9 | DNA

Continue Reading →

News

Horizon Discovery’s Dharmacon introduces Edit-R CRISPRa reagent platform for genome-wide CRISPR activation

Horizon Discovery, a global leader in gene editing and gene modulation technologies, today announced the launch of its reagent platform for CRISPR activation (CRISPR...

14 November 2017 News drug discovery | editing

Continue Reading →